Digital Diagnostics Market Report 2025

This Digital Diagnostics market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The digital diagnostics market size has grown exponentially in recent years. It will grow from $1.76 billion in 2024 to $2.16 billion in 2025 at a compound annual growth rate (CAGR) of 22.7%. The growth observed during the historic period can be attributed to factors such as rising investment and funding, growing awareness and training, increased funding for research and development (R&D), a greater emphasis on environmental, social, and governance (ESG) factors, and a shift toward more patient-centric approaches.

The digital diagnostics market size is expected to see exponential growth in the next few years. It will grow to $4.86 billion in 2029 at a compound annual growth rate (CAGR) of 22.4%. The growth projected for the forecast period can be attributed to factors such as global health initiatives, the globalization of healthcare, a cultural shift towards digital solutions, support from healthcare institutions, and the expansion of diagnostic capabilities. Key trends expected during this period include the growth of point-of-care testing, the expansion of telemedicine solutions, the development of advanced software solutions, the expansion of digital pathology solutions, and the use of blockchain technology for data security.

The rising prevalence of chronic illnesses is expected to fuel the growth of the digital diagnostics market. This increase can be attributed to factors such as aging populations, growing obesity rates, sedentary lifestyles, environmental influences, and improved awareness and diagnosis of these conditions. Digital diagnostics play a crucial role in managing chronic illnesses by enabling continuous monitoring, early detection of complications, and personalized treatment adjustments, all of which contribute to better long-term disease management and patient outcomes. For example, in February 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported approximately 20 million new cancer cases and 9.7 million cancer-related deaths in 2022. Lung cancer, with 2.5 million new cases (12.4% of all new cases), was the most common type, followed by female breast cancer (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million cases, 7.3%), and stomach cancer (970,000 cases, 4.9%). The WHO also projected that countries with high Human Development Index (HDI) would experience the most significant increase in cancer incidence, with an additional 4.8 million new cases expected by 2050 compared to 2022. Consequently, the growing number of chronic illness cases is driving the expansion of the digital diagnostics market.

Major players in the digital diagnostics market are increasingly focusing on creating advanced products such as digital cytology systems to improve diagnostic precision, streamline processes, and enable remote analysis using advanced imaging and AI-based tools. A digital cytology system is an innovative diagnostic platform that leverages imaging technology and artificial intelligence to assess and interpret cytological samples, ensuring more accurate and efficient diagnoses. For example, in February 2024, Hologic Inc., a medical technology company based in the United States, received approval from the U.S. Food and Drug Administration (FDA) for its Genius Digital Diagnostics System, which includes the Genius Cervical AI algorithm. This system is the first FDA-cleared digital cytology platform that combines deep-learning AI with advanced volumetric imaging to detect pre-cancerous lesions and cervical cancer cells. Unlike conventional methods, where cervical cells from a Pap test are examined manually under a microscope, the Genius system digitizes the slides and uses AI to highlight important cells, which cytologists and pathologists can then review.

In October 2023, Kingsway Financial Services, a holding company based in the United States, acquired Digital Diagnostics Imaging for $11 million. This acquisition allows Kingsway Financial Services to strengthen its healthcare portfolio by incorporating Digital Diagnostics Imaging's remote cardiac monitoring services. The addition of these services is expected to generate recurring revenue and broaden Kingsway's presence in the expanding telehealth market. Digital Diagnostics Imaging is a US-based company that specializes in providing digital diagnostic systems and services.

Major players in the digital diagnostics market are Hoffmann-La Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Koninklijke Philips N.V., General Electric Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., Fulgent Genetics Inc., Guardant Health Inc., Tempus Labs Inc., Genomic Health Inc., EDX Medical Inc., PathAI Inc., Healthy.io Ltd., BrightInsight Inc., Digital Diagnostics Inc., Brainomix Limited, DnaNudge Ltd., and GRAIL Inc.

North America was the largest region in the digital diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in digital diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the digital diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Digital diagnostics refers to the use of advanced digital technologies, including artificial intelligence (AI), machine learning, data analytics, and imaging systems, to identify, monitor, and predict health conditions with high precision and efficiency. By utilizing electronic health records (EHRs), wearable devices, and diagnostic tools, real-time data collection, analysis, and interpretation can assist healthcare professionals in making accurate medical decisions.

The main products in digital diagnostics include hardware, software, and services. Hardware refers to the physical devices used for conducting tests and collecting health data. These technologies are applied in various fields, such as cardiology, gynecology, infectious diseases, oncology, diabetes, and more. They are used by hospitals, clinics, clinical laboratories, pharmaceutical and biotechnology companies, academic and research institutions, among others.

The digital diagnostics market research report is one of a series of new reports that provides digital diagnostics market statistics, including digital diagnostics industry global market size, regional shares, competitors with a digital diagnostics market share, detailed digital diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the digital diagnostics industry. This digital diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital diagnostics market consists of revenues earned by entities by providing services such as remote patient monitoring, digital imaging analysis, telehealth diagnostics, and genomic and biomarker analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital diagnostics market also includes sales of digital X-ray systems, point-of-care testing devices, pathology slide scanners, and genetic testing kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.